Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • yzzhang
    Member
    • Jan 2013
    • 67

    maker weird thing

    Hi, all.
    Now I use maker pipeline to annotate my assembly. I have two computers, one has 8 cores, 96 G memory, another has 12 cores, 96 g memory. Because I want to run faster, I split my assembly to two parts and run maker on the two computers, one part has fewer but more longer scaffolds, the other part has more scaffolds with shorter length.I used mpich2 and run: mpiexec -n 8 (or 12) maker, I set the same parameters for maker, but I tried to run the part containing long scaffolds on the 8 cores computer. many scaffolds failed to be annotated, while run this part on the 12 cores computer, it worked good, and annotated successfully. I fell weird, any one knew why? Thanks a lot.
    Best wishes,
    yun
  • yzzhang
    Member
    • Jan 2013
    • 67

    #2
    BTW, I saw the run log named run.log.child.0 for the failed scaffold said " DIED RANK 5:2:0:0
    DIED COUNT 1"
    but the same scaffold run on the 12 cores computer this scaffold was annotated successfully, the run.log.child.0 was empty. Any questions?

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM
    • GATTACAT
      Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
      by GATTACAT
      Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
      07-01-2026, 11:43 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    34 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-07-2026, 11:05 AM
    0 responses
    34 views
    0 reactions
    Last Post SEQadmin2  
    Working...